Screener
Oruka Therapeutics, Inc. ORKA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
FAQ
- What is Oruka Therapeutics, Inc.'s free cash flow?
- Oruka Therapeutics, Inc. (ORKA) reported free cash flow of -$23.65M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s free cash flow changed year-over-year?
- Oruka Therapeutics, Inc.'s free cash flow decreased by 13.3% year-over-year, from -$20.88M to -$23.65M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Oruka Therapeutics, Inc.'s free cash flow has grown at a 67.5% compound annual growth rate (CAGR), from -$18.81M to -$88.42M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Oruka Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude